for moderate to severe frown lines (glabellar lines) beyond 6 months These results reinforce RelabotulinumtoxinA’s 6-month clinical effect and rapid onset from Day 1 demonstrated in the phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback